About Us
Our mission is to empower people living with neuromuscular diseases to live longer, more independent lives.
Press Releases
-
Dec 19, 2019MDA is focused on driving innovations in research and care for people living with neuromuscular diseases.
-
Dec 13, 2019Second approved exon-skipping therapy for Duchenne muscular dystrophy
-
Dec 9, 2019An experienced drug development executive focused on neuromuscular disease, neuroscientist Dr. Hesterlee brings a unique background in the pharma, biotech and nonprofit sectors
-
Dec 6, 2019
-
Dec 5, 2019
-
Nov 21, 2019Panelists will be attending live and via webcast, including live polling, to ensure a broad range of experiences and lifestyles are shared with FDA, Biopharmaceutical companies and key stakeholders
Press Releases
-
Dec 19, 2019MDA is focused on driving innovations in research and care for people living with neuromuscular diseases.
-
Dec 13, 2019Second approved exon-skipping therapy for Duchenne muscular dystrophy
-
Dec 9, 2019An experienced drug development executive focused on neuromuscular disease, neuroscientist Dr. Hesterlee brings a unique background in the pharma, biotech and nonprofit sectors
-
Dec 6, 2019
-
Dec 5, 2019
-
Nov 21, 2019Panelists will be attending live and via webcast, including live polling, to ensure a broad range of experiences and lifestyles are shared with FDA, Biopharmaceutical companies and key stakeholders
